STEPHANIE ANGEL: Open Payments
NPI 1689050668 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,955 in 102 payments from 13 companies in 2025. Trend: 2023 $402 · 2024 $1,286 · 2025 $1,955
Food & beverage: $1,955
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $461 |
| Janssen Biotech, Inc. | 18 | $307 |
| ABBVIE INC. | 30 | $284 |
| Madrigal Pharmaceuticals | 7 | $260 |
| Olympus America Inc. | 2 | $172 |
| GENZYME CORPORATION | 5 | $112 |
| QOL Medical, LLC | 6 | $100 |
| Janssen Scientific Affairs, LLC | 1 | $91 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Ardelyx, Inc. | 2 | $33 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, DUPIXENT, LINZESS, RINVOQ, Sucraid, Single Use Repositionable Clip.
Industry payments across IN — which companies pay providers there.
